Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Soloway

Showing results (281-290 of 307) with videos related to

Pageof 31
Sort By:
Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.
Southern Medical Journal|November 1, 1983
Use of tumor colony assay in clinical oncologyH B Niell, C L Neely, C A Wood, et al.
JAMA|August 21, 1987
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgeryW U Shipley, G R Prout, A B Einstein, et al.
Cancer|April 15, 1993
Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasiaG W Jones, R A Smith, J D Batjer, et al.
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
The Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
Cancer|May 15, 1987
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of lifeC A Presant, M S Soloway, S S Klioze, et al.
Pageof 31

Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
Urology|January 11, 1991
Zoladex versus orchiectomy in treatment of advanced prostate cancer: a randomized trial. Zoladex Prostate Study GroupM S Soloway, G Chodak, N J Vogelzang, et al.
BJU International|June 15, 1999
Endocrine effects, efficacy and tolerability of a 10.8-mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancerM F Sarosdy, P F Schellhammer, M S Soloway, et al.
Southern Medical Journal|November 1, 1983
Use of tumor colony assay in clinical oncologyH B Niell, C L Neely, C A Wood, et al.
JAMA|August 21, 1987
Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgeryW U Shipley, G R Prout, A B Einstein, et al.
Cancer|April 15, 1993
Workgroup #3: Monitoring effects of treatment for cancer and for benign prostatic hyperplasiaG W Jones, R A Smith, J D Batjer, et al.
Der Urologe. Ausg. A|April 24, 2001
[Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]S H Hautmann, G L Schroeder, F Civantos, et al.
The Journal of Urology|August 1, 1995
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancerM F Sarosdy, R W deVere White, M S Soloway, et al.
Cancer|March 1, 1984
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepaB F Issell, G R Prout, M S Soloway, et al.
The Journal of Urology|March 1, 1992
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancerD L Lamm, P M van der Meijden, A Morales, et al.
Cancer|May 15, 1987
Buserelin treatment of advanced prostatic carcinoma. Long-term follow-up of antitumor responses and improved quality of lifeC A Presant, M S Soloway, S S Klioze, et al.
Pageof 31